Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 11 (4) , 380-386
- https://doi.org/10.1016/s0952-7915(99)80064-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Fas-Fas Ligand Interactions Play a Major Role in Effector Functions of Cytotoxic T Lymphocytes after Adenovirus Vector-Mediated Gene TransferHuman Gene Therapy, 1999
- Lung-Specific Expression of Adenovirus E3-14.7K in Transgenic Mice Attenuates Adenoviral Vector-Mediated Lung Inflammation and Enhances Transgene ExpressionHuman Gene Therapy, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cellsEuropean Journal of Immunology, 1998
- The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB SignalImmunity, 1998
- Apoptosis by Death FactorCell, 1997
- Tumor Necrosis Factor α Induces the Adenovirus Early 3 Promoter by Activation of NF-κBPublished by Elsevier ,1996
- TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling ComplexImmunity, 1996
- Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses.The Journal of cell biology, 1993